Electric buses save STM thousands daily: Concordia study
Montreal's electric bus fleet could generate significant daily savings for STM even in winter conditions, according to new Concordia University research. Learn how this impacts public transit.
Montreal's electric bus fleet could generate significant daily savings for STM even in winter conditions, according to new Concordia University research. Learn how this impacts public transit.
New data reveals Canada rejected record numbers of Indian student applications with approval rates falling 93% in two years. Learn about the policy shifts affecting international education.
Pfizer triumphs in dramatic $10 billion bidding war for obesity drug maker Metsera, securing crucial White House-backed deal to compete in weight-loss market. Read the full story.
The Ontario government has awarded a crucial contract to study the feasibility of constructing an underground tunnel beneath Highway 401, potentially transforming Toronto's traffic landscape and creating new transportation corridors.
Former President Donald Trump unveils ambitious strategy to dramatically reduce costs of groundbreaking weight-loss medications, promising relief for millions struggling with obesity.
The Ontario government is investing $9.1 million in a feasibility study for Premier Doug Ford's visionary plan to build tunnels beneath Highway 401, potentially revolutionizing Toronto-area transportation.
Former President Trump's proposal to regulate Medicare drug prices faces unexpected consequences as Democrats leverage it to attack Republican positions on healthcare, creating political turmoil.
A transformative medical partnership between Canadian and US hospitals will provide free genomic testing to 100,000 Canadians, revolutionizing personalized healthcare and disease prevention.
Former President Donald Trump reveals groundbreaking agreement with pharmaceutical giant to make obesity drugs more affordable and accessible across the United States.
Major pharmaceutical giants Novo Nordisk and Eli Lilly experience significant stock surges as former President Donald Trump considers a groundbreaking obesity drug partnership, potentially revolutionizing weight loss treatment accessibility.
Groundbreaking research exposes the vaping epidemic among BC youth, with startling statistics about usage patterns and health concerns that demand immediate action.
Optigo Biotherapeutics strengthens leadership with renowned pharmaceutical expert Dr. Andreas Wallnofer joining its Board of Directors as the company progresses toward Investigational New Drug (IND) enabling studies.
Groundbreaking Canadian research shows your daily step count could be a powerful weapon against Alzheimer's disease. Discover how simple walking habits may protect cognitive function.
The FDA's principal deputy commissioner, Dr. Namandjé Bumpus, resigns following federal probe into undisclosed concerns about her conduct, marking significant leadership shakeup.
Ardena strengthens its leadership with strategic hires of Chief Quality Officer and Chief Information Officer to drive operational excellence and digital transformation in pharmaceutical services.
In a landmark move reshaping the consumer healthcare landscape, Kimberly-Clark announces its acquisition of Kenvue, the company behind Tylenol and other household brands, in a staggering US$48.7 billion transaction that creates a new industry powerhouse.
In a landmark healthcare deal, Kimberly-Clark acquires Kenvue, the consumer health giant behind Tylenol, Band-Aid and Listerine, reshaping the North American healthcare landscape.
New Canadian research shows national happiness significantly improves population health, but only when countries pass a crucial economic development threshold. Discover the science behind the happiness-health connection.
Groundbreaking research from Dartmouth College challenges whether expensive high-definition televisions provide visible benefits beyond what human eyes can actually perceive.
International students in Toronto and Ottawa are being denied entry to Canadian institutions despite being fully vaccinated with WHO-approved COVID-19 vaccines not recognized by Health Canada.
Health Canada issues urgent recall for specific blood pressure medications containing potentially carcinogenic nitrosamine impurity. Learn which lots are affected and what steps to take.
Pharmaceutical giant Eli Lilly reports explosive growth driven by Mounjaro and Zepbound, creating intense investor competition and reshaping the obesity treatment landscape.
Pharmaceutical giants and startups race to develop next-generation weight-loss treatments as demand soars and market valuations skyrocket in this healthcare revolution.
Global pharmaceutical leader Boehringer Ingelheim secures exclusive license from Kyowa Kirin to develop innovative autoimmune disease treatment, targeting conditions like lupus and rheumatoid arthritis with novel therapeutic approach.
A former Melita pharmacy manager faces consequences after being convicted of multiple professional misconduct charges, including improper prescription practices and record-keeping failures.
Groundbreaking research from Canadian scientists shows that even moderate nighttime light exposure can disrupt sleep patterns and increase cardiovascular risks. Discover how your bedroom environment might be affecting your health.
New Canadian research exposes the limitations of BMI, revealing millions with normal weight may have 'hidden obesity' and face serious health risks. Discover the silent epidemic your scale isn't showing you.
New research shows Montreal trailing significantly in economic performance compared to other large North American urban centers, raising concerns about the city's competitive edge.
New OQLF study investigates alarming trend of youth disengaging from French in Quebec. Discover the factors behind this linguistic shift and what it means for the province's future.